US Pharma MarketingThe post Novanta outlays $1.45bn for Riverpoint Medical buyout appeared first on Medical Device Network.
Novanta outlays $1.45bn for Riverpoint Medical buyout
The deal will give Novanta entry into the minimally invasive surgery segment and is expected to bolster it position in the medical consumables space. The deal will give Novanta entry into the minimally invasive surgery segment and is expected to bolster it position in the medical consumables space. Novanta anticipates that its acquisition of Riverpoint Medical will complete in Q3 2026. Credit: Piotr Swat / Shutterstock.com Novanta has agreed to acquire Riverpoint Medical for an upfront price of $1.2bn to expand its portfolio into the minimally invasive surgery segment and advance its medical consumables revenue. Novanta, which develops components spanning…
The deal will give Novanta entry into the minimally invasive surgery segment and is expected to bolster it position in the medical consumables space.
Source: Medical Device Network